Shortage of Novo Nordisk’s (NVO) Weight Loss Drugs Is Resolved, Says FDA
The shortage of Novo Nordisk’s (NVO) blockbuster weight loss drugs has been resolved, according to the U.S. Food and Drug Administration ...
Nasdaq19d
Vertex Pharmaceuticals Just Won a Huge FDA Approval. Is the Biotech Stock a No-Brainer Buy?
Vertex Pharmaceuticals (NASDAQ: VRTX) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 days. On Dec. 20, 2024, the FDA gave a thumbs-up to Alyftrek in treating ...
FDA declares Wegovy and Ozempic shortage over, Novo Nordisk confirms
Novo Nordisk (NVO) announced that the U.S. Food and Drug Administration has determined the shortage of Wegovy and Ozempic is resolved. “The ...
Nasdaq19d
Is Vertex Pharmaceuticals a Buy Now That the FDA Approved Its New Pain Drug?
Shares of Vertex Pharmaceuticals (NASDAQ: VRTX) are down about 9% from a peak the stock set in November, despite some highly positive news. The U.S. Food and Drug Administration (FDA) approved ...
MassDevice3h
iRhythm stock rises on Q4 results, on-target FDA remediation efforts
Rhythm (Nasdaq: IRTC) shares got a boost today on fourth-quarter results that came in ahead of the consensus forecast on Wall ...
Nasdaq23d
Adial Pharmaceuticals Completes Pharmacokinetics Study of AD04, Prepares for FDA End-of-Phase 2 Interaction
We have engaged with the FDA on the results of this PK bridging ... and our ability to retain our key employees or maintain our Nasdaq listing. These risks should not be construed as exhaustive ...
Nasdaq25d
Alvotech: FDA To Review BLA For AVT05 - Quick Facts
The FDA review process is anticipated to be completed ... and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New ...
Nasdaq23d
HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software
The FDA submission is backed by robust data from ... About HeartBeam, Inc. HeartBeam, Inc. (NASDAQ: BEAT) is a medical technology company dedicated to transforming the detection and monitoring ...
Nasdaq15d
Eton Pharmaceuticals Announces FDA Extension of PDUFA Goal Date for ET-400 New Drug Application
The FDA has extended the PDUFA goal date for ... Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments ...
Nasdaq25d
BIIB Secures FDA Nod for Monthly Maintenance Dosing of Alzheimer's Drug
The FDA’s latest approval is supported by modeling ... Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months.
Nasdaq21d
Axsome Gets FDA Nod for New Migraine Drug Symbravo, Stock Rises
FDA Nod for Symbravo Diversifies AXSM's Product ... the average surprise being 28.70%. From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in ...
Nasdaq14d
Iterum Therapeutics Receives FDA Approval for ORLYNVAH™ and Reports Extended Cash Runway
ORLYNVAH™ received FDA approval in the fourth quarter of 2024 ... DUBLIN and CHICAGO, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a company focused on delivering ...